Reflections on the Innovative Medicines Initiative

被引:26
|
作者
Goldman, Michel [1 ]
机构
[1] Innovat Med Initiat, B-1060 Brussels, Belgium
关键词
D O I
10.1038/nrd3434
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public-private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
引用
收藏
页码:321 / 322
页数:2
相关论文
共 50 条
  • [31] THE INNOVATIVE MEDICINES INITIATIVE: A PUBLIC PRIVATE PARTNERSHIP MODEL TO FOSTER DRUG DISCOVERY
    Vaudano, Elisabetta
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2013, 6 (07): : e201303017
  • [32] The Innovative Medicines Initiative-10 Years of Public-Private Collaboration
    Laverty, Hugh
    Meulien, Pierre
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [33] INNOVATIVE MEDICINES INITIATIVE IN THE ANDALUSIAN REGION. ON THE FRONTIER OF ADVANCED CLINICAL PHARMACOLOGY
    Lucena, M. I.
    Hernandez, C.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 15 - 15
  • [35] Editorial: The Innovative Medicines Initiative - collaborations are key to innovating R&D processes
    Laverty, Hugh
    Goldman, Michel
    [J]. BIOTECHNOLOGY JOURNAL, 2014, 9 (09) : 1095 - 1096
  • [36] The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project
    Teare, Harriet J. A.
    de Masi, Federico
    Banasik, Karina
    Barnett, Anna
    Herrgard, Sanna
    Jablonka, Bernd
    Postma, Jacqueline W. M.
    McDonald, Timothy J.
    Forgie, Ian
    Chmura, Piotr J.
    Rydzka, Emil K.
    Gupta, Ramneek
    Brunak, Soren
    Pearson, Ewan
    Kaye, Jane
    [J]. LIFE SCIENCES SOCIETY AND POLICY, 2018, 14
  • [37] Medicines for all initiative
    Gupton, Frank
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [38] DILI revisited - key results from the innovative medicines initiative MIP-DILI project
    Hewitt, P.
    Weaver, R. J.
    [J]. TOXICOLOGY LETTERS, 2019, 314 : S43 - S43
  • [39] The innovative medicines initiative IMI-A new collaborative approach to drug safety testing and beyond
    Gottwald, Matthias
    [J]. TOXICOLOGY LETTERS, 2009, 189 : S265 - S265
  • [40] The Innovative Medicines Initiative: a case study for new ways of working in drug R&D
    Laverty, Hugh
    Goldman, Michel
    [J]. FUTURE MEDICINAL CHEMISTRY, 2014, 6 (05) : 489 - 491